Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Dec;96(12):918-24.
doi: 10.1111/j.1349-7006.2005.00129.x.

Enhanced efficacy of radiation-induced gene therapy in mice bearing lung adenocarcinoma xenografts using hypoxia responsive elements

Affiliations

Enhanced efficacy of radiation-induced gene therapy in mice bearing lung adenocarcinoma xenografts using hypoxia responsive elements

Wei-Dong Wang et al. Cancer Sci. 2005 Dec.

Abstract

The aim of the present study was to investigate whether the hypoxia responsive element (HRE) could be used to enhance suicide gene (HSV-tk) expression and tumoricidal activity in radiation-controlled gene therapy of human lung adenocarcinoma xenografts. A chimeric promoter, HRE-Egr, was generated by directly linking a 0.3-kb fragment of HRE to a 0.6-kb human Egr-1 promoter. Retroviral vectors containing luciferase or the HSV-tk gene driven by Egr-1 or HRE-Egr were constructed. A human adenocarcinoma cell line (A549) was stably transfected with the above vectors using the lipofectamine method. The sensitivity of transfected cells to prodrug ganciclovir (GCV) and cell survival rates were analyzed after exposure to a dose of 2 Gy radiation and hypoxia (1%). In vivo, tumor xenografts in BALB/c mice were transfected with the constructed retroviruses and irradiated to a total dose of 6 Gy, followed by GCV treatment (20 mg/kg for 14 days). When the HSV-tk gene controlled by the HRE-Egr promoter was introduced into A549 cells by a retroviral vector, the exposure to 1% O(2) and 2 Gy radiation induced significant enhancement of GCV cytotoxicity to the cells. Moreover, in nude mice bearing solid tumor xenografts, only the tumors infected with the hybrid promoter-containing virus gradually disappeared after GCV administration and radiation. These results indicate that HRE can enhance transgene expression and tumoricidal activity in HSV-tk gene therapy controlled by ionizing radiation in hypoxic human lung adenocarcinoma.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Retroviral constructs used in this study. A deletion in the U3 region of the 3′ long terminal repeats (LTR) of the retroviral vector pBABA puro was introduced (dLTR) to generate the self‐inactivating (SIN) vector pBABE puro SIN. The inserts consisting of the HSV‐tk or Luc genes with the Egr‐1 promoter and hypoxia responsive element (HRE) enhancer are indicated.
Figure 2
Figure 2
Enhancement of radio‐inducible transcriptional activity from the Egr‐1 promoter by hypoxic response elements (HRE) after transient transfection exposure to hypoxia. A549 cells were infected with the luciferase reporter constructs SEL or HRE‐SEL and incubated in normoxia (N) or hypoxia (H) (1%) for 8 h with exposure to 2 Gy of radiation (R). Twelve hours later, these cells were harvested and assayed for luciferase activity. The luciferase activity were normalized to that in non‐irradiated cells under aerobic conditions. The error bars in all of the figures show the standard deviation (SD) of at least five independent samples. Versus SEL: **P < 0.01; versus N + R : #P < 0.05, ##P < 0.01.
Figure 3
Figure 3
HSV‐tk expression in parental and infected A549 cells. The HSV‐tk of the SET and HRE–SET groups and glyceraldehyde‐3‐phosphate dehydrogenase (GAPDH)‐specific transcripts are shown. Lane 1, untreated infected cells at normoxia; lane 2, infected cells under hypoxia (1%); lanes 3–4, infected cells exposed to 2 Gy radiation with or without hypoxia (1%), respectively.
Figure 4
Figure 4
Concentration of ganciclovir (GCV) yielding 50% growth inhibition (IC50) in vitro in parental A549 cells, and in SET‐ or HRE–SET‐infected cells exposed to radiation with normoxia (R + N) or hypoxia (1%) (R + H). Cell viability was assayed by using the trypan blue exclusion test. The IC50 was calculated using curve‐fitting parameters. Versus SET: ##P < 0.01; versus R + N: **P < 0.01.
Figure 5
Figure 5
In vitro suicide gene therapy of A549 cells infected with either the SET or HRE–SET retrovirus. Cells infected with the recombinant retroviruses were incubated with 10 µM ganciclovir for 6 days, and exposed to 2 Gy radiation (R) and/or hypoxia (1%) (H) for 8 h previously every 2 days, followed by cell survival analysis. Data are representative of at least five separate experiments. Each bar represents the mean ± SD (n = 5–8).
Figure 6
Figure 6
CA IX staining photographs. (a) Peripheral view. (b) Central view. Both slices are shown at ×25 magnification. Scale bar = 40 µm. N, necrosis; P, CA IX positive staining; V, viable, well‐oxygenated tumor tissue. The arrow indicates a blood vessel.
Figure 7
Figure 7
In vivo suicide gene therapy in solid tumor xenografts consisting of A549 cells. The nude mice bearing the subcutaneous tumors were infected with either SET or HRE–SET retroviruses, followed by daily intraperitoneal injection of 20 mg/kg ganciclovir (GCV) for 2 weeks, with exposure to 2 Gy radiation on days 2, 4 and 6. Tumor size was measured every 2 days. Control, A549 cells injection only; H + G, HRE–SET transfection and GCV; H + R, HRE–SET transfection and radiation; H + R + G, HRE–SET transfection, radiation and GCV; R, A549 injection and radiation; S + G, SET transfection and GCV; S + R, SET transfection and radiation; S + R + G, SET transfection, radiation and GCV.

Similar articles

Cited by

References

    1. Kufe D, Weichselbaum R. Radiation therapy: activation for gene transcription and the development of genetic radiotherapy‐therapeutic strategies in oncology. Cancer Biol Ther 2003; 2: 326–9. - PubMed
    1. Datta R, Taneja N, Sukhatme VP et al. Reactive oxygen intermediates target CC (A/T) 6GG sequences to mediate activation of the early growth response 1 transcription factor gene by ionizing radiation. Proc Natl Acad Sci USA 1993; 90: 2419–22. - PMC - PubMed
    1. Xia J, Xia K, Feng Y et al. The combination of suicide gene therapy and radiation enhances the killing of nasopharyngeal carcinoma xenographs. J Radiat Res (Tokyo) 2004; 45: 281–9. - PubMed
    1. Hsu H, Rainov NG, Quinones A et al. Combined radiation and cytochrome CYP4B1/4‐ipomeanol gene therapy using the EGR1 promoter. Anticancer Res 2003; 23: 2723–8. - PubMed
    1. Hallahan DE, Weichselbaum RR. Role of gene therapy in radiation oncology. Cancer Treat Res 1998; 93: 153–67. - PubMed

Publication types

MeSH terms